Ombre
Latest round
- Seed
Last raised
- Feb 2022
Total raised
- $4M
Investors
- 3
About Ombre
Founded in 2016 and based in California, US, Thryve, Inc. trading under the name Ombre, operates as a developer of monthly subscription microbiotics testing solutions that enable users to receive personal insights and health recommendations based on their results. In August 2024, Thryve, Inc. Ombre provides a digital solution for gut health through at-home microbiome testing, personalized microbiome reports, and targeted probiotic supplements. The microbiome test kit allows users to collect a sample at home, which is analyzed using DNA sequencing to detect bacterial strains in the gut. Based on this analysis, Ombre provides personalized food recommendations and tailored probiotic formulations to promote digestive health. The entire process is supported by a proprietary bioinformatics pipeline that processes data and generates customized wellness suggestions.
Who invested in Ombre
3 investors across 2 rounds
See all investors in Ombre
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ombre
Who invested in Ombre?
Ombre has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ombre raised?
Ombre has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Ombre last raise money?
Ombre's most recent round on record is a Seed, in Feb 2022.
What does Ombre do?
Founded in 2016 and based in California, US, Thryve, Inc.
Where is Ombre headquartered?
Ombre is headquartered in San Francisco, US.
Which VCs invest in companies like Ombre?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Ombre's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Ombre? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.